Author: BusinessWire

Publication of results from Phase 4 single-arm, open-label study in 91 healthy adults, age 20-40 years, to confirm reference standard…

VANCOUVER, British Columbia & MONTREAL–(BUSINESS WIRE)–Versant Ventures today announced the filing of an early warning report with respect to the…

Positive first results from the complete dose-finding part of a phase Ib/II study of tumor-agnostic NBTXR3 (PEP503) activated by radiotherapy…

Positive first results from the complete dose-finding part of a phase Ib/II study of tumor-agnostic NBTXR3 (PEP503) activated by radiotherapy…

GAITHERSBURG, Md.–(BUSINESS WIRE)–Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced…

– Data Presented at the 2021 ASCO GI Cancers Symposium – BOSTON–(BUSINESS WIRE)–AVEO Oncology (Nasdaq: AVEO) today announced the presentation…

DUBLIN–(BUSINESS WIRE)–The “Computational Biology Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026” report has been added…

DUBLIN–(BUSINESS WIRE)–The “Computational Biology Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026” report has been added…

DUBLIN–(BUSINESS WIRE)–The “Computational Biology Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026” report has been added…

Collaboration Also Secures Strategic Investment from Amgen Ventures DURHAM, N.C.–(BUSINESS WIRE)–Target RWE, a leading real-world evidence (RWE) solutions company for…